Extended half-life rFIX in major surgery-How to improve clinical practice: An intraindividual comparison.

extended half‐life FIX hemophilia B major surgery orthopedic pharmacokinetic real‐life experience

Journal

Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385

Informations de publication

Date de publication:
Mar 2020
Historique:
received: 11 06 2019
revised: 19 08 2019
accepted: 27 08 2019
entrez: 19 3 2020
pubmed: 19 3 2020
medline: 19 3 2020
Statut: epublish

Résumé

Practical, safe, and effective hemostatic approach to orthopedic surgery using Extended Half-Life factor IX in hemophilia B. By intraindividual comparison, we found a lower FIX consumption, number of infusions, and cost compared to plasma-derived FIX.

Identifiants

pubmed: 32185052
doi: 10.1002/ccr3.2450
pii: CCR32450
pmc: PMC7069879
doi:

Types de publication

Case Reports

Langues

eng

Pagination

531-534

Informations de copyright

© 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.

Déclaration de conflit d'intérêts

FV: is an accommodation consultant bureau for Roche and Bayer. AB: is an accommodation consultant bureau for Roche, Kedrion, Bayer, and Novo Nordisk. JAG: is an accommodation consultant bureau for Kedrion and received honoraria from Pfizer. CD: is an accommodation consultant bureau for Novo Nordisk.

Références

Haemophilia. 2013 Jan;19(1):e1-47
pubmed: 22776238
Br J Haematol. 2009 Apr;145(2):227-34
pubmed: 19236610
Orthop Surg. 2017 Nov;9(4):359-364
pubmed: 29178312
J Manag Care Spec Pharm. 2018 Jul;24(7):643-653
pubmed: 29363389
Br Med J. 1979 Feb 17;1(6161):469-70
pubmed: 427411
Haemophilia. 2016 Jul;22(4):487-98
pubmed: 27311929
J Clin Med. 2017 Mar 28;6(4):
pubmed: 28350322
Hip Int. 2018 Sep;28(5):459-467
pubmed: 30124085
Haemophilia. 2011 Jan;17(1):e196-201
pubmed: 20618876
Haemophilia. 2012 Jan;18(1):86-93
pubmed: 21649799
Br J Haematol. 2015 Jan;168(1):124-34
pubmed: 25208598
Haemophilia. 2018 Jul;24(4):611-618
pubmed: 29707861
Haemophilia. 2002 Mar;8(2):91-7
pubmed: 11952843

Auteurs

Federica Valeri (F)

Haematology Unit Regional Center for Hemorrhagic and Thrombotic Diseases City of Health and Science University Hospital of Molinette Turin Italy.

Jacopo Agnelli Giacchello (J)

Haematology Unit Regional Center for Hemorrhagic and Thrombotic Diseases City of Health and Science University Hospital of Molinette Turin Italy.

Cristina Dainese (C)

Haematology Unit Regional Center for Hemorrhagic and Thrombotic Diseases City of Health and Science University Hospital of Molinette Turin Italy.

Alessandra Valpreda (A)

Regional Center for Hemorrhagic and Thrombotic Diseases Haematology Laboratory City of Health and Science University Hospital of Molinette Turin Italy.

Barbara Montaruli (B)

Hematological Laboratoy Mauriziano Hospital Turin Italy.

Enrico Dosio (E)

Regional Center for Hemorrhagic and Thrombotic Diseases Haematology Laboratory City of Health and Science University Hospital of Molinette Turin Italy.

Mario Boccadoro (M)

Haematology Unit Regional Center for Hemorrhagic and Thrombotic Diseases City of Health and Science University Hospital of Molinette Turin Italy.

Alessandra Borchiellini (A)

Haematology Unit Regional Center for Hemorrhagic and Thrombotic Diseases City of Health and Science University Hospital of Molinette Turin Italy.

Classifications MeSH